What is puraply used for in wound care?
INTENDED USE: It can be used to manage bioburden while supporting healing across a wide variety of wound types, regardless of severity or duration. CLAIMED FEATURES: PuraPly Antimicrobial utilizes an inherently strong biocompatible fenestrated sheet of porcine-derived collagen coated with PHMB.
How can I get more information about puraply™ products?
For information about specific products, please contact the manufacturer directly. PuraPly™ Antimicrobial is purified native collagen matrix with the antimicrobial polyhexamethylene biguanide (PHMB). INTENDED USES: To manage bioburden while supporting healing across a wide variety of wound types, regardless of severity or duration.
What is puraply antimicrobial?
PuraPly™ Antimicrobial is purified native collagen matrix with the antimicrobial polyhexamethylene biguanide (PHMB). INTENDED USES: To manage bioburden while supporting healing across a wide variety of wound types, regardless of severity or duration.
When can I use puraply am after sharp debridement?
USE PURAPLY AM AS EARLY AS DAY 1.* Bioburden management with PuraPly AM following sharp debridement helps you move wounds out of the inflammatory phase. *Certain local coverage determinations may not allow skin substitute use until after conventional care at week 4.
PuraPly AM. Right from the start. For control all week long
Get wounds moving as early as day 1 with the power of plus—native cross-linked ECM + broad-spectrum PHMB antimicrobial—backed by multiple real-world effectiveness studies and scientific evidence. 1-7
REAL-WORLD STUDY: PURAPLY AM SUPPORTED HEALING IN LARGE, DIFFICULT-TO-HEAL WOUNDS
The first prospective, large (N=307), multicenter (28 sites) cohort study of PuraPly AM showed that 86% of all PuraPly AM-treated wounds demonstrated improvement in the wound bed condition. 1
What is PuraPly AM?
PuraPly AM is an FDA 510 (k)-cleared Class II medical device indicated for acute and chronic wound management across a wide variety of wound types, including partial- and full-thickness wounds, pressure ulcers, surgical wounds, trauma wounds, and venous and diabetic ulcers. It is available in a range of sizes to meet the needs of a variety of wound types.
Is Organogenesis a regenerative medicine company?
Canton, MA, March 4, 2019 – Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that a new case series published in Plastic and Reconstructive Surgery – Global Open suggests PuraPly ® Antimicrobial (PuraPly AM) positively affects the course of healing in a variety of complex, chronic wounds that were previously unresponsive to treatment.
Does WoundReference sell healthcare products?
Unbiased information for educational purposes only. WoundReference does not produce, market, advertise, re-sell or distribute healthcare goods or services consumed by, or used on patients. For information about specific products, please contact the manufacturer directly. Technology and Product Assessment:
Can product properties change?
The properties of a product may change or be inaccurate following the posting or printing of the product information in the document, either in the print or online version. Due to product changes, information listed in this document is subject to change without notice.
